Abstract
A series of new low molecular weight peptide inhibitors, antistasin and ghilantens fragment analogues was designed and synthesized by manual solid phase peptide synthesis. These compounds only differ either by the amino acid placed in position 109 (different basic amino acids) and 115 position (Val or Ile) or 116 position Pro (as free acid or as amide). The anticoagulant activity of the different synthesized peptide mimetics was measured. Further the IC50 was obtained by means of Activated Partial Thromboplastin Time measurement. Using Mihaelis–Menthen equation the mixed type of inhibition toward thrombin and Factor Xa is determined.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brandstetter H, Kuhne A, Bode W, Huber R, Saal W, Wirthensohni K, Engh RA (1996) X-ray structure of active site-inhibited clotting factor Xa. Implication for drug design and substrate recognition. J Biol Chem 271:29988–29992
Brankamp RG, Sreekrishna K, Smith PL, Blankenship DT, Cardin AD (1995) Expression of a synthetic gene encoding the anticoagulant–antimetastatic protein ghilanten by the methylotropic yeast Pichia pastoris. Protein Exp Purif 6:813–820
Danalev D, Vezenkov L, Grigorova B (2005) Design, synthesis and structure–activity relationship of a series of fragment analogues of antistasin (ATS) and ghilantens (GLS). Bioorg Med Chem Lett 15:4217–4220
Danalev D, Yotova L, Vezenkov L (2006) Investigation of kinetic parameters in vitro of serine proteinases included in the blood coagulation cascade. Protein Pept Lett 13:535–537
Dunwiddie C, Thornberry NA, Bull HG, Sardana M, Friedman PA, Jacobs JW, Simpson E (1989) Antistasin, a leech—derived inhibitor of factor Xa: kinetic analysis of enzyme inhibition and identification of the reactive site. J Biol Chem 264:16694–16699
Faria F, Kelen EM, Sampaio CA, Bon C, Duval N, Chudzinski-Tavassi AM (1999) A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech. Thromb Haemost 82:1469–1473
Fischer PM (2003) Diketopiperazines in peptide and combinatorial chemistry. J Pept Sci 9:9–35
Gould R, Shafer J (1993) Perspectives in drug discovery and design 1. Design of antithrombotic agents: an introduction. Springer, Dordrecht, pp 419–422
Mao SS, Huang J, Neeper ME, Shafer JA (1993) Perspectives in drug discovery and design 1. Factor Xa inhibitors. Springer, Dordrecht, pp 423–430
Theunissen HJ, Dijkema R, Swinkels JC, De Poorter TL, Vink PM, Van Dinter TG (1994) Mutational analysis of antistasin, an inhibitor of blood coagulation factor Xa derived from the Mexican leech Haementeria officinalis. Thromb Res 75:41–50
Tuszynski GP, Gasic TB, Gasic GJ (1987) Isolation and characterization of antistasin, an inhibitor of metastasis and coagulation. J Biol Chem 262:9718–9723
Yildiz E, Grübler G, Hörger S, Zimmermann H, Echner H (1994) Peptides, proteins and nucleic acids. Biological and biomedical applications, solid phase synthesis of C-terminal proline peptides using an anchor system suppressing diketopiperasine formation. An innovation and perspective in solid phase synthesis. Mayflower Worldwide, Birmingham, pp 517–520
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Danalev, D.L., Vezenkov, L.T., Lozanov, V. et al. Design, Synthesis and Structure–Activity Relationship of New 109–116 Fragment Analogues of Antistasin and Ghilantens. Int J Pept Res Ther 16, 107–110 (2010). https://doi.org/10.1007/s10989-010-9209-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-010-9209-9